These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32351322)

  • 21. Transcriptomic Signatures in Colorectal Cancer Progression.
    Ershov P; Poyarkov S; Konstantinova Y; Veselovsky E; Makarova A
    Curr Mol Med; 2023; 23(3):239-249. PubMed ID: 35490318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms investigation for liver metastasis of colorectal cancer by combined bioinformatic gene expression profile analysis.
    Wu QQ; Wang XY; Wu WX; Chen YX; Wang J; Zhang X; Qian Y; Du SS; Sun J; Zeng ZC
    Cancer Treat Res Commun; 2023; 35():100694. PubMed ID: 36868002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma: a study based on cross-database analysis.
    Yang W; Zhou W; Zhao X; Wang X; Duan L; Li Y; Niu L; Chen J; Zhang Y; Han Y; Fan D; Hong L
    Hereditas; 2021 Apr; 158(1):15. PubMed ID: 33892811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel diagnostic and prognostic biomarkers of colorectal cancer: Capable to overcome the heterogeneity-specific barrier and valid for global applications.
    Hameed Y; Usman M; Liang S; Ejaz S
    PLoS One; 2021; 16(9):e0256020. PubMed ID: 34473751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
    Liang B; Li C; Zhao J
    Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of 6 Hub Proteins and Protein Risk Signature of Colorectal Cancer.
    Yue T; Liu C; Zhu J; Huang Z; Guo S; Zhang Y; Xu H; Liu Y; Wang P; Chen S
    Biomed Res Int; 2020; 2020():6135060. PubMed ID: 33376727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer.
    Yang X; Wei W; Tan S; Guo L; Qiao S; Yao B; Wang Z
    World J Surg Oncol; 2021 Aug; 19(1):248. PubMed ID: 34419055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Network cluster analysis of protein-protein interaction network identified biomarker for early onset colorectal cancer.
    Luo T; Wu S; Shen X; Li L
    Mol Biol Rep; 2013 Dec; 40(12):6561-8. PubMed ID: 24197691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of butyrate-metabolism in colorectal cancer to guide clinical treatment.
    Luo Q; Zhou P; Chang S; Huang Z; Zeng X
    Sci Rep; 2023 Mar; 13(1):5106. PubMed ID: 36991138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The key genes underlying pathophysiology association between the type 2-diabetic and colorectal cancer.
    Peng WF; Bai F; Shao K; Shen LS; Li HH; Huang S
    J Cell Physiol; 2018 Nov; 233(11):8551-8557. PubMed ID: 29319171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of intestinal flora-related key genes and therapeutic drugs in colorectal cancer.
    Zhang J; Zhang H; Li F; Song Z; Li Y; Zhao T
    BMC Med Genomics; 2020 Nov; 13(1):172. PubMed ID: 33198757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer.
    Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X
    Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses.
    Tang D; Zhao X; Zhang L; Wang Z; Wang C
    J Cell Biochem; 2019 Jun; 120(6):9522-9531. PubMed ID: 30506958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hub Genes and Key Pathway Identification in Colorectal Cancer Based on Bioinformatic Analysis.
    Lv J; Li L
    Biomed Res Int; 2019; 2019():1545680. PubMed ID: 31781593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrative analyses of molecular pathways and key candidate biomarkers associated with colorectal cancer.
    Pirim D
    Cancer Biomark; 2020; 27(4):555-568. PubMed ID: 32176635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
    Zhang L; Sun L; Zhang B; Chen L
    Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Machine Learning Predicts the Oxidative Stress Subtypes Provide an Innovative Insight into Colorectal Cancer.
    Zhong H; Yang L; Zeng Q; Chen W; Zhao H; Wu L; Qin L; Yu QQ
    Oxid Med Cell Longev; 2023; 2023():1737501. PubMed ID: 37122535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma.
    Zhang BH; Yang J; Jiang L; Lyu T; Kong LX; Tan YF; Li B; Zhu YF; Xi AY; Xu X; Yan LN; Yang JY
    Genomics; 2020 Jul; 112(4):2763-2771. PubMed ID: 32198063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.